SEC Form D private-offering filing
ARTELO BIOSCIENCES, INC.
A new SEC Form D private-offering notice from Solana Beach, CA, a $3,718,121 filer-stated offering target in Biotech. The source filing is one click away.
Clinical stage biopharmaceutical company developing lipid signaling therapeutics for cancer, anorexia, anxiety, pain and inflammation, publicly traded on Nasdaq as ARTL
Filed 2025-11-10Filed to raise $3,718,121First money in 2025-10-28Raised so far $3,718,121HQ (as filed) Solana Beach, CASector Biotech ✓Stage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified artelobio.com↗Named in the filing 8 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.